Search by Drug Name or NDC

    NDC 43066-0008-10 TRANEXAMIC ACID 100 mg/mL Details

    TRANEXAMIC ACID 100 mg/mL

    TRANEXAMIC ACID is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is TRANEXAMIC ACID.

    Product Information

    NDC 43066-0008
    Product ID 43066-008_d16fa2b3-f9ba-4d64-b7b2-19f2a1a39ef3
    Associated GPIs 84100040002025
    GCN Sequence Number 068183
    GCN Sequence Number Description tranexamic acid VIAL 1000 MG/10 INTRAVEN
    HIC3 M9D
    HIC3 Description ANTIFIBRINOLYTIC AGENTS
    GCN 30912
    HICL Sequence Number 002802
    HICL Sequence Number Description TRANEXAMIC ACID
    Brand/Generic Generic
    Proprietary Name TRANEXAMIC ACID
    Proprietary Name Suffix n/a
    Non-Proprietary Name tranexamic acid
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name TRANEXAMIC ACID
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212360
    Listing Certified Through 2024-12-31

    Package

    NDC 43066-0008-10 (43066000810)

    NDC Package Code 43066-008-10
    Billing NDC 43066000810
    Package 10 CARTON in 1 BOX (43066-008-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (43066-008-01)
    Marketing Start Date 2020-07-01
    NDC Exclude Flag N
    Pricing Information N/A